SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-073277
Filing Date
2017-03-07
Accepted
2017-03-07 16:05:56
Documents
3
Period of Report
2017-03-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d344407d8k.htm 8-K 15168
2 EX-99.1 d344407dex991.htm EX-99.1 117815
3 GRAPHIC g344407g0306212245974.jpg GRAPHIC 2031
  Complete submission text file 0001193125-17-073277.txt   137127
Mailing Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709
Business Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709 919-313-9650
AERIE PHARMACEUTICALS INC (Filer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36152 | Film No.: 17672002
SIC: 2836 Biological Products, (No Diagnostic Substances)